A glioma is a type of tumor that occurs in the brain or spine, which arises from glial cells. Based on the histological features, Gliomas are mainly classified into ependymomas (develop in ependymal cells), astrocytomas (develop in astrocytes), Oligodendrogliomas (develop in oligodendrocytes), brainstem glioma (develop in the brain stem), Optic nerve glioma (develop in or around the optic nerve) and mixed gliomas (develop in other different types of glia). Because the sites of affected central nervous system are various, the symptoms of gliomas are different. For instance, a glioma in the brain can result in headaches, vomiting, seizures, and cranial nerve disorders caused by increased intracranial pressure. A glioma developing in the optic nerve can cause visual loss. Treatment for gliomas depends on the location of cancer, the cell types, and the grade of disease. Normally, surgery, radiation therapy, and chemotherapy with a combined approaches are used. Considering that these traditional methods have certain side effects, we provide CellRapeutic™ CAR products targeting glioma-specific antigens to assist your development of new treatments in clinical trials.
People classify Glioma into these types:
All services and products are only for lab research use, not for any clinical diagnosis or treatment.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MOREAngiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORETRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE